Donations
If you find this site
informative please donate, every
donation helps us keep up
with hosting costs.
Thanks!
Warrants
Alert
Books
THE INVESTOR'S GUIDE TO WARRANTS:
Capitalize on the Fastest Growing Sector of the
Stock Market, Second Edition (Hardcover)
by Andrew McHattie Rating: ISBN-10: 027303751X
Name - BiomX Inc
Current / Former Name: Chardan Healthcare Acquisition Corp. (Predecessor)
Address: 7 Oppenheimer Street, Rehovot 7670107, Israel
Phone Number: +972 8-942-3300
Investor Relations Contact: info@biomx.com
Website - https://www.biomx.com
Warrant Symbol: PHGEW / PHGE.WS
Warrants Listed: 7,000,000
Ratio: 1-for-1
Cusip Number: 08918A 11 6
Expiry Date - October 28, 2024
Exercise Price: $11.50
Synopsis & Listing Information
Synopsis: BiomX Inc. is a clinical-stage microbiome platform company. It focuses on developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria associated with chronic medical conditions like cystic fibrosis, inflammatory bowel disease, and colorectal cancer.
Listing History: The company began public market operations as a blank-check entity under the name Chardan Healthcare Acquisition Corp. The company's initial units traded under CHACU, while the embedded warrants detached onto the NYSE American under the temporary trading symbol CHAC.WS.
Business Combination: On October 28, 2019, Chardan Healthcare Acquisition Corp. completed its formal international business combination with BiomX Ltd., an Israeli phage therapeutics company. Following the combination, the surviving parent public corporation was officially renamed BiomX Inc.
Ticker Change: Upon the completion of the business combination, the capital ticker symbols transitioned on the exchange. The underlying common equity shifted to PHGE, and the public warrants migrated from CHAC.WS to the new primary symbol PHGEW (also appearing on various financial data systems as PHGE.WS).
Reverse Split Adjustment: N/A
Current Status: As of May 2026, the public warrants under symbol PHGEW are completely historical and inactive. They reached their absolute 5-year expiration deadline on October 28, 2024. Any unexercised warrants were canceled out of the capitalization tables. Active underlying company options and private financing warrants still exist.
Current / Former Name: Chardan Healthcare Acquisition Corp. (Predecessor)
Address: 7 Oppenheimer Street, Rehovot 7670107, Israel
Phone Number: +972 8-942-3300
Investor Relations Contact: info@biomx.com
Website - https://www.biomx.com
Warrant Symbol: PHGEW / PHGE.WS
Warrants Listed: 7,000,000
Ratio: 1-for-1
Cusip Number: 08918A 11 6
Expiry Date - October 28, 2024
Exercise Price: $11.50
Synopsis & Listing Information
Synopsis: BiomX Inc. is a clinical-stage microbiome platform company. It focuses on developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria associated with chronic medical conditions like cystic fibrosis, inflammatory bowel disease, and colorectal cancer.
Listing History: The company began public market operations as a blank-check entity under the name Chardan Healthcare Acquisition Corp. The company's initial units traded under CHACU, while the embedded warrants detached onto the NYSE American under the temporary trading symbol CHAC.WS.
Business Combination: On October 28, 2019, Chardan Healthcare Acquisition Corp. completed its formal international business combination with BiomX Ltd., an Israeli phage therapeutics company. Following the combination, the surviving parent public corporation was officially renamed BiomX Inc.
Ticker Change: Upon the completion of the business combination, the capital ticker symbols transitioned on the exchange. The underlying common equity shifted to PHGE, and the public warrants migrated from CHAC.WS to the new primary symbol PHGEW (also appearing on various financial data systems as PHGE.WS).
Reverse Split Adjustment: N/A
Current Status: As of May 2026, the public warrants under symbol PHGEW are completely historical and inactive. They reached their absolute 5-year expiration deadline on October 28, 2024. Any unexercised warrants were canceled out of the capitalization tables. Active underlying company options and private financing warrants still exist.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...
Visitor Map
Days Left
Warrant Terms
- Expiration Date: The last day the warrants can be exercised. If warrants aren't going to be exercised then they must be sold the day before the expiry date. The longer the time to expiry the more valuable the warrants.
- Leverage: A measure of how much you can increase your exposure to a share if you bought warrants instead of making a direct investment. It is the current share price divided by the current price of the warrant.
- Intrinsic Value: The difference between the exercise price and the actual trading price of the common stock. Once the common has gone over the exercise price, the warrants are "In the Money."
- Volatility: The higher the volatility rating, the higher the price of the warrant. Historical volatility is calculated by using the standard deviation of an underlying stock price over a specific period.
- Time Value: The difference between the current warrant price and its intrinsic value. Interpreted as the consideration paid for the advantage the warrant buyer has over the direct investor.
Charts
Gold Prices
Silver Prices
Platinum Prices
Palladium Prices
Visitors